Vir Biotechnology, Inc. · NASDAQ:VIR
The Vanguard Group's stake in Vir Biotechnology, Inc. fell below 5% (Schedule 13G/A)
Event Mar 13, 2026 · Filed Mar 27, 2026
The Vanguard Group's stake in Vir Biotechnology, Inc. fell below 5%, 0 shares, as a passive investor on Mar 13, 2026. Filed Mar 27, 2026 (Schedule 13G/A).
- Stake
- 0%
- Shares
- 0
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 0% | 0 |
Source
Related
- Vir Biotechnology, Inc.
- The Vanguard Group
- Vir Biotechnology, Inc. shareholders
- Form 4 · More Robert J · Aug 12, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Schedule 13G/A · Vanguard Portfolio Management LLC · Jul 31, 2026
- Form 4 · Coughlin Timothy · Jun 10, 2026
- Form 4 · Napolitano Janet · Jun 2, 2026